Figure S7. A schematic showing the novel mechanism of TIM-1+ Breg cells in HCC progression. Based on our data, we propose a model involving TIM-1+ Breg cells in HCC progression. First, HCC cells release exosomes with the potential to promote the accumulation of TIM-1+Breg cells through the HMGB1-TLR2/4-MAPK pathway. Second, TIM-1+Breg cells create an immunosuppressive microenvironment through secreting IL-10 and impairing CD8+ T cell functions, which provide favorable conditions for HCC progression. Third, myeloid cells further strengthen the immunosuppressive function of TIM-1+Breg cells through TIM-1/TIM-4 signaling. (TIF 13079 kb
Figure S6. Role of PI3K/AKT signaling in CD73 mediating HCC progression. (A) Expressions of EMT-rela...
Figure S4. LX2 cells-derived COMP promotes tumor progression. A) The plate colony formation assay wa...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Figure S5. Tumor-derived exosomes promoted TIM-1+B cell expansion via TLR2/4. (A) On day 3, CD19+ B ...
Figure S6. Tumor-derived exosomes did not promote TIM-1+B cell expansion via autophagy. (A) B cells ...
Abstract Background Regulatory B (Breg) cells represent one of the B cell subsets that infiltrate so...
Table S6. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S1. TIM-1+ B cells strongly infiltrated lung carcinoma tissue. (A) The TIM-1+B cells in the t...
Figure S4. HMGB1 produced in culture was not derived from the active or passive release of HMGB1 by ...
Table S5. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Figure S5. In vivo function of CD73 in HCC. (A) Representative IHC images of PCNA expression level i...
Figure S8. Recombinant HMGB1 induced autophagy and promoted the activation of neutrophils. A. The pe...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Figure S6. Role of PI3K/AKT signaling in CD73 mediating HCC progression. (A) Expressions of EMT-rela...
Figure S4. LX2 cells-derived COMP promotes tumor progression. A) The plate colony formation assay wa...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Figure S5. Tumor-derived exosomes promoted TIM-1+B cell expansion via TLR2/4. (A) On day 3, CD19+ B ...
Figure S6. Tumor-derived exosomes did not promote TIM-1+B cell expansion via autophagy. (A) B cells ...
Abstract Background Regulatory B (Breg) cells represent one of the B cell subsets that infiltrate so...
Table S6. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S1. TIM-1+ B cells strongly infiltrated lung carcinoma tissue. (A) The TIM-1+B cells in the t...
Figure S4. HMGB1 produced in culture was not derived from the active or passive release of HMGB1 by ...
Table S5. Univariate and Multivariate Analysis of Prognostic Factors for recurrence-free survival an...
Figure S2. Tumor-derived exosomes activated HSCs in vitro. a Flow cytometry assays of cell cycle sho...
Figure S5. In vivo function of CD73 in HCC. (A) Representative IHC images of PCNA expression level i...
Figure S8. Recombinant HMGB1 induced autophagy and promoted the activation of neutrophils. A. The pe...
Figure S4. Tumor-derived exosomes activated HSCs in vivo. a Immunohistochemistry imaging of Ki67 sho...
Figure S6. Role of PI3K/AKT signaling in CD73 mediating HCC progression. (A) Expressions of EMT-rela...
Figure S4. LX2 cells-derived COMP promotes tumor progression. A) The plate colony formation assay wa...
Additional file 1: Supplementary Figure S1. Exosomes derived from CD133+ cells enhance the malignant...